Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of an Oral, Selective Peripheral Opioid Receptor Antagonist in Advanced Non-Small Cell Lung Cancer
Sponsor: Alliance for Clinical Trials in Oncology
Terminated
Insufficient accrual
Other terminated trials from Alliance for Clinical Trials in Oncology
- Diabetes · Mar 2025
- Node Positive HER2 Negative Breast Cancer · Phase PHASE3 · Feb 2023
- Brain Metastases · Phase PHASE2 · Dec 2022
- Malignant Neoplasm · Phase PHASE3 · Aug 2022
- Breast Carcinoma · Jul 2022
See all terminations from Alliance for Clinical Trials in Oncology
This PHASE2 trial investigates Stage IIIB Non-Small Cell Lung Cancer and Stage IV Non-small Cell Lung Cancer and is currently terminated or withdrawn. Alliance for Clinical Trials in Oncology leads this study, which shows 38 recorded versions since 2018 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
38 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE2
-
Aug 2025 — Sep 2025 [monthly]
Terminated PHASE2
-
Mar 2025 — Aug 2025 [monthly]
Terminated PHASE2
-
Sep 2024 — Mar 2025 [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
▶ Show 33 earlier versions
-
Jun 2023 — Jul 2024 [monthly]
Terminated PHASE2
Status: Active Not Recruiting → Terminated
-
Jan 2023 — Jun 2023 [monthly]
Active Not Recruiting PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Active Not Recruiting PHASE2
-
Sep 2022 — Dec 2022 [monthly]
Active Not Recruiting PHASE2
-
Jun 2021 — Sep 2022 [monthly]
Active Not Recruiting PHASE2
-
Feb 2021 — Jun 2021 [monthly]
Active Not Recruiting PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting PHASE2
-
Aug 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Jul 2020 — Aug 2020 [monthly]
Recruiting PHASE2
-
Jun 2020 — Jul 2020 [monthly]
Recruiting PHASE2
-
May 2020 — Jun 2020 [monthly]
Recruiting PHASE2
-
Apr 2020 — May 2020 [monthly]
Recruiting PHASE2
-
Mar 2020 — Apr 2020 [monthly]
Recruiting PHASE2
-
Feb 2020 — Mar 2020 [monthly]
Recruiting PHASE2
-
Dec 2019 — Feb 2020 [monthly]
Recruiting PHASE2
-
Nov 2019 — Dec 2019 [monthly]
Recruiting PHASE2
-
Oct 2019 — Nov 2019 [monthly]
Recruiting PHASE2
-
Sep 2019 — Oct 2019 [monthly]
Recruiting PHASE2
-
Jul 2019 — Sep 2019 [monthly]
Recruiting PHASE2
-
Jun 2019 — Jul 2019 [monthly]
Recruiting PHASE2
-
May 2019 — Jun 2019 [monthly]
Recruiting PHASE2
-
Apr 2019 — May 2019 [monthly]
Recruiting PHASE2
-
Feb 2019 — Apr 2019 [monthly]
Recruiting PHASE2
-
Jan 2019 — Feb 2019 [monthly]
Recruiting PHASE2
-
Oct 2018 — Jan 2019 [monthly]
Recruiting PHASE2
-
Sep 2018 — Oct 2018 [monthly]
Recruiting PHASE2
-
Aug 2018 — Sep 2018 [monthly]
Recruiting PHASE2
-
Jul 2018 — Aug 2018 [monthly]
Recruiting PHASE2
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE2
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE2
Phase: PHASE3 → PHASE2
-
Nov 2017 — May 2018 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Jun 2017 — Nov 2017 [monthly]
Not Yet Recruiting PHASE3
Phase: NA → PHASE3
-
May 2017 — Jun 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Alliance for Clinical Trials in Oncology
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .